These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nanoparticles in cancer chemotherapy. Banerjee D; Sengupta S Prog Mol Biol Transl Sci; 2011; 104():489-507. PubMed ID: 22093227 [TBL] [Abstract][Full Text] [Related]
3. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment. Ho BN; Pfeffer CM; Singh ATK Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776 [TBL] [Abstract][Full Text] [Related]
4. Nanotechnology Approaches to Improving Cancer Immunotherapy. Hagan CT; Medik YB; Wang AZ Adv Cancer Res; 2018; 139():35-56. PubMed ID: 29941106 [TBL] [Abstract][Full Text] [Related]
5. Cancer, signal transduction and nanotechnology. Sengupta P; Basu S; Sengupta S Curr Drug Deliv; 2011 May; 8(3):254-60. PubMed ID: 21291374 [TBL] [Abstract][Full Text] [Related]
6. The potential legacy of cancer nanotechnology: cellular selection. Patra HK; Turner AP Trends Biotechnol; 2014 Jan; 32(1):21-31. PubMed ID: 24246361 [TBL] [Abstract][Full Text] [Related]
7. Nanotechnology-based approaches in anticancer research. Jabir NR; Tabrez S; Ashraf GM; Shakil S; Damanhouri GA; Kamal MA Int J Nanomedicine; 2012; 7():4391-408. PubMed ID: 22927757 [TBL] [Abstract][Full Text] [Related]
8. Targeting of nanoparticles in cancer: drug delivery and diagnostics. Talekar M; Kendall J; Denny W; Garg S Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851 [TBL] [Abstract][Full Text] [Related]
9. Phytofabrication of Nanoparticles as Novel Drugs for Anticancer Applications. Wei QY; He KM; Chen JL; Xu YM; Lau ATY Molecules; 2019 Nov; 24(23):. PubMed ID: 31766544 [TBL] [Abstract][Full Text] [Related]
10. Smart Nanotherapeutic Targeting of Tumor Vasculature. Li Z; Di C; Li S; Yang X; Nie G Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171 [TBL] [Abstract][Full Text] [Related]
11. Potentials and challenges of active targeting at the tumor cells by engineered polymeric nanoparticles. Mukherjee B; Satapathy BS; Mondal L; Dey NS; Maji R Curr Pharm Biotechnol; 2013; 14(15):1250-63. PubMed ID: 24910012 [TBL] [Abstract][Full Text] [Related]
12. Molecular imaging in drug development: Update and challenges for radiolabeled antibodies and nanotechnology. Colombo I; Overchuk M; Chen J; Reilly RM; Zheng G; Lheureux S Methods; 2017 Nov; 130():23-35. PubMed ID: 28743635 [TBL] [Abstract][Full Text] [Related]
14. Polymeric nanoparticles for cancer therapy. Parveen S; Sahoo SK J Drug Target; 2008 Feb; 16(2):108-23. PubMed ID: 18274932 [TBL] [Abstract][Full Text] [Related]
15. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Sinha R; Kim GJ; Nie S; Shin DM Mol Cancer Ther; 2006 Aug; 5(8):1909-17. PubMed ID: 16928810 [TBL] [Abstract][Full Text] [Related]
16. Functional nanoplatforms for enhancement of chemotherapeutic index. Yang J; Lee E; Ku M; Huh YM; Cheong JH Anticancer Agents Med Chem; 2013 Feb; 13(2):212-21. PubMed ID: 22934694 [TBL] [Abstract][Full Text] [Related]
17. Targeting different signaling pathways with antisense oligonucleotides combination for cancer therapy. Leonetti C; Zupi G Curr Pharm Des; 2007; 13(5):463-70. PubMed ID: 17348843 [TBL] [Abstract][Full Text] [Related]
18. Bridging cancer biology and the patients' needs with nanotechnology-based approaches. Fonseca NA; Gregório AC; Valério-Fernandes A; Simões S; Moreira JN Cancer Treat Rev; 2014 Jun; 40(5):626-35. PubMed ID: 24613464 [TBL] [Abstract][Full Text] [Related]
19. Nanosize drug delivery system. Mukherjee B Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648 [TBL] [Abstract][Full Text] [Related]
20. Threatening cancer with nanoparticle aided combination oncotherapy. Rawal S; Patel MM J Control Release; 2019 May; 301():76-109. PubMed ID: 30890445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]